{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:00:12Z","timestamp":1791648012645,"version":"4.3.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":700,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>The epidemiology and natural history of pediatric primary sclerosing cholangitis (PSC), autoimmune sclerosing cholangitis (ASC), and autoimmune hepatitis (AIH) are not well characterized. Using multiple, overlapping search strategies followed by a detailed records review, we identified all cases of pediatric PSC, ASC, AIH, and inflammatory bowel disease (IBD) in a geographically isolated region of the United States. We identified 607 cases of IBD, 29 cases of PSC, 12 cases of ASC, and 44 cases of AIH. The mean age at diagnosis was 13.0 years for PSC, 11.3 years for ASC, and 9.8 years for AIH. The incidence and prevalence of PSC, ASC, and AIH were 0.2 and 1.5 cases, 0.1 and 0.6 cases, and 0.4 and 3.0 cases per 100,000 children, respectively. The mean duration of follow-up was 5.9 years. The probability of developing complicated liver disease within 5 years of the diagnosis of liver disease was 37% [95% confidence interval (CI) = 21%-58%] for PSC, 25% (95% CI = 7%-70%) for ASC, and 15% (95% CI = 7%-33%) for AIH. The 5-year survival rates with the native liver were 78% (95% CI = 54%-91%) for PSC, 90% (95% CI = 47%-99%) for ASC, and 87% (95% CI = 71%-95%) for AIH. Cholangiocarcinoma developed in 2 of the 29 PSC patients (6.9%). PSC occurred in 9.9% of patients with ulcerative colitis (UC) and in 0.6% of patients with Crohn's disease (CD). ASC occurred in 2.3% of UC patients and 0.9% of CD patients. AIH occurred in 0.4% of UC patients and in 0.3% of CD patients. Liver disease occurred in 39 of 607 IBD patients (6.4%) overall.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion\n                                 <\/jats:bold>\n                                 <jats:bold>: Immune-mediated liver diseases are important sources of morbidity in children. Using a population-based design, this study quantifies the burden and natural history of immune-mediated liver disease in children. (Hepatology 2013;58:1392\u20131400)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26454","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T13:31:58Z","timestamp":1368797518000},"page":"1392-1400","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":217,"title":["Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in utah children: Epidemiology and natural history"],"prefix":"10.1097","volume":"58","author":[{"given":"Mark","family":"Deneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle M.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Holmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Book","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Guthery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20241201","doi-asserted-by":"crossref","first-page":"239245","DOI":"10.1016\/j.cgh.2008.10.019","article-title":"A retrospective singlecenter review of primary sclerosing cholangitis in children.","volume":"7","author":"Miloh","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-25-20241201","doi-asserted-by":"crossref","first-page":"210217","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: a longterm followup study.","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"R3-25-20241201","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1097\/00054725-199503000-00003","article-title":"Characterization of hepatic abnormalities in children with inflammatory bowel disease.","volume":"1","author":"Hyams","year":"1995","journal-title":"Inflamm Bowel Dis"},{"key":"R4-25-20241201","doi-asserted-by":"crossref","first-page":"544553","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitissclerosing cholangitis overlap syndrome in childhood: a 16year prospective study.","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"R5-25-20241201","doi-asserted-by":"crossref","first-page":"660678","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis.","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"R6-25-20241201","doi-asserted-by":"crossref","first-page":"191198","DOI":"10.1016\/j.jhep.2010.01.037","article-title":"Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials.","volume":"53","author":"Lamers","year":"2010","journal-title":"J Hepatol"},{"key":"R7-25-20241201","doi-asserted-by":"crossref","first-page":"746764","DOI":"10.1002\/hep.21337","article-title":"Primary sclerosing cholangitis: summary of a workshop.","volume":"44","author":"LaRusso","year":"2006","journal-title":"Hepatology"},{"key":"R8-25-20241201","doi-asserted-by":"crossref","first-page":"11811188","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"R9-25-20241201","doi-asserted-by":"crossref","first-page":"10421049","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a populationbased analysis.","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R10-25-20241201","first-page":"99103","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"R11-25-20241201","doi-asserted-by":"crossref","first-page":"13641369","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"R12-25-20241201","doi-asserted-by":"crossref","first-page":"24022407","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives.","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R13-25-20241201","first-page":"376379","article-title":"Autoimmune hepatitis in children in eastern Denmark.","volume":"55","author":"VitfellPedersen","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R14-25-20241201","doi-asserted-by":"crossref","first-page":"565568","DOI":"10.1155\/2007\/757906","article-title":"Retrospective review of pediatric and adult autoimmune hepatitis in two quaternary care centres in British Columbia: increased prevalence seen in British Columbias First Nations community.","volume":"21","author":"Chung","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"R15-25-20241201","first-page":"138A","article-title":"Incidence and characteristics of autoimmune hepatitis in children and adolescents in Canada: a preliminary report of the Canadian Pediatric Hepatology Research Group abstract.","volume":"54","author":"JimenezRivera","year":"2012","journal-title":"Hepatology"},{"key":"R16-25-20241201","doi-asserted-by":"crossref","first-page":"975983","DOI":"10.1002\/ibd.20144","article-title":"Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC).","volume":"13","author":"Dassopoulos","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"suppl 1","key":"R17-25-20241201","first-page":"4349","article-title":"Surgical pathology of the syndrome of primary sclerosing cholangitis.","volume":"13","author":"Ludwig","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"R18-25-20241201","doi-asserted-by":"crossref","first-page":"249264","DOI":"10.1016\/S1089-3261(05)70006-4","article-title":"Histopathology of chronic cholestasis and adult ductopenic syndrome.","volume":"2","author":"Desmet","year":"1998","journal-title":"Clin Liver Dis"},{"key":"R19-25-20241201","doi-asserted-by":"crossref","first-page":"169176","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis.","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"R20-25-20241201","doi-asserted-by":"crossref","first-page":"417421","DOI":"10.1016\/j.cgh.2011.11.030","article-title":"Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children.","volume":"10","author":"Mileti","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-25-20241201","doi-asserted-by":"crossref","first-page":"617620","DOI":"10.1097\/MPG.0b013e3181f9a5d2","article-title":"Cholangiocarcinoma in a 17yearold boy with primary sclerosing cholangitis and inflammatory bowel disease.","volume":"52","author":"Deneau","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R22-25-20241201","doi-asserted-by":"crossref","first-page":"16811686","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Populationbased epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R23-25-20241201","doi-asserted-by":"crossref","first-page":"610615","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"R24-25-20241201","doi-asserted-by":"crossref","first-page":"562566","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"R25-25-20241201","doi-asserted-by":"crossref","first-page":"541547","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20year experience.","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"R26-25-20241201","doi-asserted-by":"crossref","first-page":"724728","DOI":"10.1016\/j.dld.2010.01.002","article-title":"Autoimmune hepatitis in childrenimpact of cirrhosis at presentation on natural history and longterm outcome.","volume":"42","author":"Radhakrishnan","year":"2010","journal-title":"Dig Liver Dis"},{"key":"R27-25-20241201","first-page":"326343","article-title":"The overlap syndromes of autoimmune hepatitis.","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R30-25-20241201","doi-asserted-by":"crossref","first-page":"775779","DOI":"10.1002\/ibd.20384","article-title":"Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouchanal anastomosis.","volume":"14","author":"Lepisto","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R31-25-20241201","doi-asserted-by":"crossref","first-page":"153161","DOI":"10.3109\/00365529709000186","article-title":"Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.","volume":"32","author":"Heikius","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R32-25-20241201","doi-asserted-by":"crossref","first-page":"308313","DOI":"10.1097\/MPG.0b013e31825bb3dc","article-title":"Investigative MRI cholangiopancreatography for primary sclerosing cholangitistype lesions in children with IBD.","volume":"55","author":"Alexopoulou","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R33-25-20241201","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1097\/MCG.0b013e3181574636","article-title":"Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey.","volume":"43","author":"Tozun","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R34-25-20241201","doi-asserted-by":"crossref","first-page":"140145","DOI":"10.1097\/MPG.0b013e3181ca4db4","article-title":"Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity.","volume":"51","author":"Dotson","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R35-25-20241201","doi-asserted-by":"crossref","first-page":"110119","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R36-25-20241201","doi-asserted-by":"crossref","first-page":"10121023","DOI":"10.1111\/j.1572-0241.2006.00504.x","article-title":"Inflammatory bowel disease characteristics among African Americans, Hispanics, and nonHispanic whites: characterization of a large North American cohort.","volume":"101","author":"Nguyen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R37-25-20241201","doi-asserted-by":"crossref","first-page":"11161122","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a populationbased study.","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R38-25-20241201","doi-asserted-by":"crossref","first-page":"149153","DOI":"10.1111\/j.1445-5994.1994.tb00550.x","article-title":"Sclerosing cholangitis in children with inflammatory bowel disease.","volume":"24","author":"Ong","year":"1994","journal-title":"Aust N Z J Med"},{"key":"R39-25-20241201","doi-asserted-by":"crossref","first-page":"13191323","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis.","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"R40-25-20241201","doi-asserted-by":"crossref","first-page":"534538","DOI":"10.1097\/MPG.0b013e31815a98ef","article-title":"Early onset of ulcerative colitis: longterm followup with special reference to colorectal cancer and primary sclerosing cholangitis.","volume":"46","author":"Lindberg","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R41-25-20241201","first-page":"738745","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"R43-25-20241201","doi-asserted-by":"crossref","first-page":"375381","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.","volume":"143","author":"Jess","year":"2012","journal-title":"Gastroenterology"},{"key":"R44-25-20241201","doi-asserted-by":"crossref","first-page":"288290","DOI":"10.1053\/j.gastro.2012.06.027","article-title":"A tale of two cohorts: are we overestimating the risk of colorectal cancer in inflammatory bowel disease?","volume":"143","author":"Nguyen","year":"2012","journal-title":"Gastroenterology"},{"key":"R45-25-20241201","doi-asserted-by":"crossref","first-page":"815825","DOI":"10.1101\/gr.085589.108","article-title":"Finescaled human genetic structure revealed by SNP microarrays.","volume":"19","author":"Xing","year":"2009","journal-title":"Genome Res"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26454","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201310000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:09:54Z","timestamp":1733062194000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201310000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26454","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}